Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3764348010 | Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
3764349019 | AbobotulinumtoxinA 500 unit lyophilized powder for solution for injection vial | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
3786513013 | AbobotulinumtoxinA 500 unit lyophilised powder for solution for injection vial | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has active ingredient | AbobotulinumtoxinA | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Is a | Product containing precisely botulinum toxin type A 500 unit/1 vial powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Lyophilized powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | Unit | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Botulinum toxin type A | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has basis of strength substance | Botulinum toxin type A | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit | Vial | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has basis of strength substance | AbobotulinumtoxinA | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | AbobotulinumtoxinA | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Is a | Product containing only abobotulinumtoxinA in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets